| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/28/2007 | CN1301993C Dimeric compounds and their use as anti-viral agents |
| 02/28/2007 | CN1301973C Heterocyclic derivatives and medicines |
| 02/28/2007 | CN1301966C 2-amino-2-alkyl-5-heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/28/2007 | CN1301964C Inhibitors of alpha 4 mediated cell adhesion |
| 02/28/2007 | CN1301738C Chinses medicine oral preparation for treating diabete and preparing method thereof |
| 02/28/2007 | CN1301733C Compound medicine for treating diabetes and its preparation process |
| 02/28/2007 | CN1301725C Wasting-thirst capsule of root powder for treating diabetes |
| 02/28/2007 | CN1301720C Biological deodorization method for dried oviduct fat of forest frog |
| 02/28/2007 | CN1301707C Danhong freeze dried powder injection agent and its preparation method |
| 02/28/2007 | CN1301665C Blood fat-regulating liver-protecting health food |
| 02/28/2007 | CN1301663C Sugar reducing bean curd |
| 02/28/2007 | CN1301655C Sugar reducing yoghurt |
| 02/28/2007 | CA2557635A1 Methods to promote cell differentiation |
| 02/27/2007 | US7183436 Substituted 4-aminocyclohexanols |
| 02/27/2007 | US7183415 Melanin-concentrating hormone antagonistic action for treating obesity, for example 4'-fluoro-N-[8-methyl-3-(1-pyrrolidinylmethyl)-7-quinolinyl][1,1'-biphenyl]-4-carboxamide |
| 02/27/2007 | US7183390 Humanized antibodies to gamma-interferon |
| 02/27/2007 | US7183321 Antidiabetic formulation and method |
| 02/27/2007 | US7183318 Substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/27/2007 | US7183317 Compounds and methods to increase plasma HDL cholesterol levels and improve HDL functionality |
| 02/27/2007 | US7183311 NF-κB inhibitors |
| 02/27/2007 | US7183307 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/27/2007 | US7183304 Heterocyclic compounds and methods of use |
| 02/27/2007 | US7183297 For therapy of rheumatoid arthritis, osteoarthritis, asthma, psoriasis, eczema, allergic rhinitis, allergic conjunctivitis, adult respiratory distress syndrome, chronic pulmonary inflammation, chronic obstructive pulmonary disease, chronic heart failure, silicosis, endotoxemia, toxic shock syndrome |
| 02/27/2007 | US7183295 Compound for treatment of lipemic agents, antiinflammatory agents and treatment of diabetes |
| 02/27/2007 | US7183294 Indole derivatives useful for the treatment of diseases |
| 02/27/2007 | US7183293 Enzyme inhibitors for phosphodiesterase isozymes for treatment of asthma, chronic bronchitis and chronic obstructive pulmonary disease |
| 02/27/2007 | US7183290 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 02/27/2007 | US7183288 2-phenylamino-4-pyrimidinecarboxamides; coupling a phenylamine with a halopyrimidine, or coupling a halobenzene with an aminopyrimidine, or amidating the 2-phenylamino-4-pyrimidylacylhalide, or oxidizing the 2-phenylamino-4-cyanopyrimidine |
| 02/27/2007 | US7183280 Bicyclic imidazole derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 02/27/2007 | US7183276 5-carbonyl or carbamido-4-(4-chlorophenyl)-2-heteroaryl oxazoles; analgesic for diabetic neuropathy |
| 02/27/2007 | US7183266 Dual induced viscosity fiber system and uses thereof |
| 02/27/2007 | US7183260 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/27/2007 | US7183254 Diagnosis, hormone replacement therapy for HIV positive females, gene therapy; metabolic disorders; antidiabetic, anticholesterol, hypoglycemic agents |
| 02/27/2007 | US7183078 Nucleotide sequences coding mammalian histamine H4 receptor protein for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders |
| 02/27/2007 | US7182971 Comprising 15-70% by weight of diglycerides in which less than 15% by weight of constitutive fatty acids are omega 3 type unsaturated fatty acids, and 30-85% by weight of a triglyceride in which at least 15% by weight of constitutive fatty acids are omega 3 type; for oral medicinal formulations and foods |
| 02/27/2007 | US7182965 pollen polyterpenes for the treatment of microbial, especially bacterial, diseases for topical, oral and parenteral administration in humans and animals |
| 02/27/2007 | US7182953 Methods and compositions for the prevention and treatment of atherosclerosis restenosis and related disorders |
| 02/27/2007 | CA2432798C Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents |
| 02/27/2007 | CA2352571C In vivo biosensor apparatus and method of use |
| 02/27/2007 | CA2256410C Stable pharmaceutical composition of bdnf |
| 02/22/2007 | WO2007022488A2 Crystalline rosuvastatin intermediate |
| 02/22/2007 | WO2007022280A1 Phosphodiesterase 10 inhibitors |
| 02/22/2007 | WO2007021529A1 Use of choline to prevent thrombosis associated with total parenteral nutrition |
| 02/22/2007 | WO2007021034A1 Scavenger of harmful active oxygen and/or free radical in living body |
| 02/22/2007 | WO2007021020A1 Capsinoid containing composition |
| 02/22/2007 | WO2007020889A1 Novel mucin glycoprotein and use thereof |
| 02/22/2007 | WO2007020888A1 Brain/neuronal cell-protecting agent, and therapeutic agent for sleep disorder |
| 02/22/2007 | WO2007020421A1 Crystalline and amorphous sodium atorvastatin |
| 02/22/2007 | WO2007020413A1 Crystalline and amorphous sodium atorvastatin |
| 02/22/2007 | WO2007020388A1 Pyrazole derivatives as therapeutic agents |
| 02/22/2007 | WO2007020286A2 Method of using potassium channel inhibiting compounds |
| 02/22/2007 | WO2007019914A1 Use of thienopyridone derivatives as ampk activators and pharmaceutical compositions containing them |
| 02/22/2007 | WO2007019646A1 Liver-directed gene therapy |
| 02/22/2007 | WO2007019618A1 Phrophylactic and/or therapeutic method for treatment of autoimmune disease |
| 02/22/2007 | WO2007001194A3 Parenteral selenomethionine for production of selenium-rich foods |
| 02/22/2007 | WO2006125632A3 Agonistic antibodies that bind to the tweak receptor fn14 and thereby modulate adiposity-associated phenotypes as well as their use in therapy |
| 02/22/2007 | WO2006091897A3 Derivatives of 8-substituted xanthines |
| 02/22/2007 | WO2006091896A3 Pyridyl substituted xanthines |
| 02/22/2007 | WO2006081431A3 Compounds for treating inflammatory and demyelinating diseases |
| 02/22/2007 | WO2006078941A3 Novel sirtuin activating compounds and methods of use thereof |
| 02/22/2007 | US20070043220 {2-Methyl-4-[3-methyl-1-(4-trifluoromethyl-phenyl)-1H-pyrazol-4-ylmethylsulfanyl]-phenoxy}-acetic acid; diabetes mellitus, Metabolic Syndrome, atherosclerosis, cardiovascular diseases,Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension |
| 02/22/2007 | US20070043206 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 02/22/2007 | US20070043095 have a good affinity for certain subtypes of somatostatin receptors and have useful pharmacological properties |
| 02/22/2007 | US20070043093 Glucagon-like peptide-1 receptor agonists, the preparation and the use of the same |
| 02/22/2007 | US20070043079 Heterocyclic compound containing nitrogen atom and use thereof |
| 02/22/2007 | US20070043078 Angiogenesis inhibitor |
| 02/22/2007 | US20070043069 3-Amino-3,4-dihydro-1,5-naphthyridin-2(1H)-one and its dihydrochloride; intermediates for producing naphthyridinylaminocarbonyl-substituted pyrrolothiopyrans and imidazolothiopyrans |
| 02/22/2007 | US20070043053 for treating p38 kinase-associated conditions like inflammatory disorders; improved dissolution rate and oral bioavailability; rheumatic diseases; skin disorders; multiple sclerosis; osteoporosis; Alzheimer's disease |
| 02/22/2007 | US20070043049 Substituted heterocyclic diarylamine analogues |
| 02/22/2007 | US20070043041 Indol-6 sulfonamide derivative, their preparation and their use 5-ht-6 as modulators |
| 02/22/2007 | US20070043029 11-Phenyl-dibenzodiazepine derivatives as rxr-antagonists |
| 02/22/2007 | US20070043027 Sulfonamide derivatives for the treatment of diabetes |
| 02/22/2007 | US20070043026 Dopamine receptor modulators as antipsychotic agents |
| 02/22/2007 | US20070043020 Benzenesulfonylamino compounds and pharmaceutical compositions containing these compounds |
| 02/22/2007 | US20070043005 Treatment of hyperproliferative diseases using high doses of active vitamin d |
| 02/22/2007 | US20070042992 Inulin products with improved nutritional properties |
| 02/22/2007 | US20070042965 Crystallized structure of type IV collagen NC1 domain hexamer |
| 02/22/2007 | US20070042964 Compositions and methods for modulating connexin hemichannels |
| 02/22/2007 | US20070042963 Therapeutic peptides |
| 02/22/2007 | US20070042947 Agents for preventing and/or treating uppper digestive tract disorders |
| 02/22/2007 | US20070042374 drug screening; obesity, diabetes mellitus, impaired glucose tolerance, arteriosclerosis, hypertension or hyperlipemia |
| 02/22/2007 | US20070042057 Compositions for the treatment and prevention of diabetes mellitus |
| 02/22/2007 | US20070042019 Method of treating or preventing chronic wounds and a complete nutritional composition comprising glycine and/or leucine for use therein |
| 02/22/2007 | US20070041996 Aromatase activating agent |
| 02/22/2007 | US20070041970 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 02/22/2007 | US20070041951 Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or exendin-4 and uses thereof |
| 02/22/2007 | CA2619769A1 Scavenger of in vivo harmful reactive oxygen species and/or free radicals |
| 02/22/2007 | CA2619505A1 Use of thienopyridone derivatives as ampk activators and pharmaceutical compositions containing them |
| 02/22/2007 | CA2619486A1 Crystalline and amorphous sodium atorvastatin |
| 02/22/2007 | CA2619480A1 Method of using potassium channel inhibiting compounds |
| 02/22/2007 | CA2619462A1 Phosphodiesterase 10 inhibitors |
| 02/22/2007 | CA2619228A1 Pyrazole derivatives as therapeutic agents |
| 02/22/2007 | CA2619145A1 Use of choline to prevent thrombosis associated with total parenteral nutrition |
| 02/22/2007 | CA2619040A1 Crystalline and amorphous sodium atorvastatin |
| 02/22/2007 | CA2618791A1 Novel mucin-type glycoprotein and use thereof |
| 02/22/2007 | CA2618653A1 Brain/neuronal cell-protecting agent and therapeutic agent for sleep disorder |
| 02/22/2007 | CA2618568A1 Thiazolyl piperidine derivatives useful as h3 receptor modulators |
| 02/21/2007 | EP1754707A2 Multicyclic compounds and their use as inhibitors of PARP, VEGFR2 and MLK3 enzymes |
| 02/21/2007 | EP1754702A1 Epigallocatechin dimers or trimers having lipase inhibitory activity and/or antioxidative activity |
| 02/21/2007 | EP1754490A2 CD 154 blockage therapy for pancreatic islet tissue transplantation in primates |